//Forge Therapeutics Scientific Co-Founder Awarded National Chemistry Honor

Forge Therapeutics Scientific Co-Founder Awarded National Chemistry Honor

San Diego, Calif., August 16, 2016 – Forge Therapeutics, Inc. announced today Dr. Seth Cohen, Ph.D., co-founder of Forge Therapeutics and Professor in the Department of Chemistry and Biochemistry at the University of California, San Diego will be receiving the Arthur C. Cope Mid Career Scholar Award at the upcoming 252nd American Chemical Society National Meeting & Exposition being held in Philadelphia from August 21-25, 2016.

 

Dr. Cohen is being honored for advancements in metal-organic chemistry and insights into the identification of innovative pharmacophores for the development of metalloprotein inhibitors. These pharmacophores form the basis of the diverse library Forge has built up to provide starting points to develop inhibitors of a broad class of metalloenzymes.

“The Forge Therapeutics platform is truly transformational providing novel chemistry solutions to high value targets that have lacked suitable approaches until now,” said Zachary A. Zimmerman, Ph.D., CEO of Forge Therapeutics. “This prestigious national chemistry award and our recent Federal funding provides further validation of our innovative approach for first-in-class and best-in-class medicines.”

 

To learn more about 2016 National Award recipients please visit: https://www.acs.org/content/acs/en/funding-and-awards/awards/national/recipients/2016-national-award-recipients.html

2017-10-09T17:28:00+00:00August 16th, 2016|

Leave A Comment